Abstract. The mutated K-ras gene is involved in ~30% of human cancers. In order to search for K-ras oncogeneinduced modulators in lung tissues of K-ras transgenic mice, we performed microarray and proteomics (LC/ESI-MS/MS) analysis. Genes (RAB27b RAS family, IL-1RA, IL-33, chemokine ligand 6, epiregulin, EGF-like domain and cathepsin) related to cancer development (Wnt signaling pathway) and inflammation (chemokine/cytokine signaling pathway, Toll receptor signaling) were up-regulated while genes (troponin, tropomodulin 2, endothelial lipase, FGFR4, integrin ·8 and adenylate cyclase 8) related to the tumor suppression such as p53 pathway, TGF-ß signaling pathway and cadherin signaling pathway were down-regulated by Kras oncogene. Proteomics approach revealed that upregulated proteins in lung adenomas of K-ras mice were classified as follows: proteins related to the metabolism/ catabolism (increased from 7 to 22% by K-ras gene), proteins related to translation/transcription and nucleotide (from 4 to 6%), proteins related to signal transduction (from 3 to 5%), proteins related to phosphorylation (from 1 to 2%). ATP synthase, Ras oncogene family, cytochrome c oxidase, flavoprotein, TEF 1, adipoprotein A-1 BP, glutathione oxidase, fatty acid BP 4, diaphorase 1, MAPK4 and transgelin were up-regulated by K-ras oncogene. However, integrin ·1, Rasinteracting protein (Rain), endothelin-converting enzyme-1d and splicing factor 3b were down-regulated. These studies suggest that genes related to cancer development and inflammation were up-regulated while genes related to the tumor suppression were down-regulated by K-ras, resulting in the tumor growth. Putative biomarkers such as cell cycle related genes (Cdc37), cancer cell adhesion (Glycam 1, integrin ·8, integrin ·X and Clec4n), signal transduction (Tlr2, IL-33, and Ccbp2), migration (Ccr1, Ccl6, and diaphorase 1 (Cyb5r3) and cancer development (epiregulin) can be useful for diagnosis and as prognosis markers and some of the target molecules can be applied for prevention of cancer.
Introduction
Lung cancer is the leading cause of cancer deaths worldwide (1) . Mutations of K-ras gene have been demonstrated in 40-50% of lung cancer and activating mutations of the K-ras oncogene are found in one-quarter to one-half of human lung adenocarcinomas. K-ras is a member of the Ras family, the most common oncogenes activated in a wide range of human cancers. Research on Ras oncogene has established mutations of three members of Ras gene family in various human cancers of tissue and organs, including urinary bladder, mammary gland, rectum, kidney, liver, lung, ovary, pancreas, stomach and the hematopoietic system. Ras proteins are activated by diverse extracellular signals, for example, via integrins or growth factors such as epidermal growth factor (EGF) and platelet-derived growth factor (PDGF) that bind to their respective receptors with tyrosine-kinase activity, or by cytokines such as interleukin-2. Activated Ras proteins then pass the stimulating signal downstream via multiple effectors that can interact synergistically (2) . Also, K-ras is a membrane-INTERNATIONAL JOURNAL OF ONCOLOGY 34: 161-172, 2009 Profiling of transcripts and proteins modulated by K-ras oncogene in the lung tissues of K-ras transgenic mice by omics approaches associated GTPase signaling protein that regulates proliferation, differentiation and cell survival (3) . The frequency of K-ras mutation has been demonstrated to be considerably high in certain types of cancers (4, 5) , such as in 75% of pancreatic tumors (6, 7) , 45% of colorectal cancers (7) and 48% of lung cancer (8) . Some studies have proposed that K-ras mutations play a significant role in the onset and progression of lung cancer (9) . In the mouse, K-ras mutations are found in >90% of spontaneous and chemically-induced lung tumors (10) . Currently, based on the results of molecular analysis of spontaneous and chemically-induced tumors in K-ras, the mutation and overexpression of the transgene are considered to be the most probable mechanisms of enhanced carcinogenesis (11) (12) (13) . Oncogenic K-ras is locked in an active form and is thus capable of activating downstream signaling cascades in the absence of external stimuli. K-ras activates effectors including the kinases Raf, PI3K, and MEKK, the GTPase Ral, and the signaling molecule AF6, which acts on gap junctions. K-ras signal transduction mediated by binding of growth factor, cytokines, or integrin also has interconnections with other major players in tumorigenesis, such as the Wnt signaling cascade (via ß-catenin destruction complex) and the tumor suppressor p53 (14) (15) (16) . In microarray and proteomics analyses, we confirmed that several genes and proteins related to cell growth, migration, cancer development, apoptosis, signaling pathway were up-and down-regulated by K-ras oncogene. To confirm induction and development of cancer by mutants, we generated the Lox-Stop-Lox K-ras
G12D
Tg mice, in which expression of oncogenic K-ras is controlled by a removable transcriptional termination Stop element (17) . In this study, the focus was on the survey of genes and proteins regulated by K-ras in lung tissues of K-ras transgenic mice. For this reason, K-ras G12D mouse was generated and the following experiments were performed as described in the Materials and methods section.
Materials and methods

Generation of K-ras transgenic mice and genotyping. K-ras
G12D
Tg mice were established by the method of DNA microinjection into embryos of BDF1 mice, as previously described (18) . Mutant K-ras G12D gene expression vector carrying human surfactant protein C (SPC) promoter was used in order to regulate mutant K-ras gene to be expressed in the lung. These mice were obtained for modulator analysis by K-ras mutant in mouse model of lung cancer. Genomic DNAs were extracted from Tg mice tails and PCR analysis was performed to analyze K-ras gene expression. The cycling conditions were as follows: 94˚C, 5 min followed by 30 cycles of 94˚C, 30 sec; 60˚C, 30 sec; 72˚C, 30 sec and 72˚C 10 min in Takara PCR thermal cycler.
Histopathological examination. Tissue samples were fixed in 10% neutral-buffered formalin, embedded in paraffin, sectioned and stained with hematoxylin/eosin according to standard methods. The histopathological diagnoses were based on the criteria described by Frith and Ward (19) .
Microarray analysis and hybridization. Gene expression analysis was conducted on the RNA samples from the lung tissues of K-ras Tg mice. Labeling and hybridization were performed by instruction of Affymetrix 430 2.0 array chips (Affymetrix, Santa Clara, CA). Hybridization was performed at 55˚C for 16 h. After washing, the slide was dried by centrifugation at 800 rpm for 3 min at RT. Hybridization images on the slides were scanned by Applied Biosystems 1700 Chemiluminescent Microarray Analyzer (Applied Biosystems, CA).
Proteomics analysis. Proteins were loaded on 4-20% TrisGlycine Gel (Invitrogen, Carlsbad, CA). The gel pieces were excised in 10 bands according to molecular weight and digested with sequencing grade modified trypsin (Promega, Madison, WI) at 12.5 ng/μl in 50 mM NH 4 HCO 3 buffer (pH 8.0) at 37˚C for overnight. The resulting tryptic peptides were loaded onto a fused silica microcapillary column (15 cm x 75 μm) packed with C18 (5 μm, 200 Å) reversed phase resin and were separated by LC using a linear gradient of 5-50% buffer A in 65 min followed by 50-90% buffer B in 5 min (buffer A: 0.1% formic acid in H 2 O, buffer B: 0.1% formic acid in acetonitrile) at a flow rate of 250 nl/min. The column was connected directly to LTQ ion-trap mass spectrometry (Thermo Finnigan, Waltham, MA) equipped with a nanoelectrospray ion source and the eluent peptides were dynamically selected for fragmentation by the operating software. Protein identification was performed by using Spectrum Mill Proteomics Workbench Version A.03.03 (Agilent Technologies). Data files were extracted using Spectrum Mill Data Extractor. Searches were carried out against the human NCBInr database in both forward and reverse directions using the Spectrum Mill program with the following parameters: specific to trypsin with two missed cleavage; ±2.5 Da precursor-ion tolerance; and ±0.7 Da fragment-ion tolerance. Carboxyamido-methylation of cysteine and oxidation of methionines were allowed as variable modifications. The initial results were auto-validated using the following parameters for details on the protein mode: SPI (scored percent intensity) >70% for matches with score >7 for +1, >9 for +1, >9 for +3, >8 for +4; and SPI >90% for score >6 on +1. The proteins were summarized by validated peptides using the following parameters: >13 for protein score; SPI >70% for score >9 on peptide; and each protein included at least 2 distinct peptide hits. A semiquantitative analysis of protein profile data was performed by comparing the total peptide intensity with the peptides of an identified protein. The total peptide intensity was obtained by summing up the peptide intensities of the peptide hits for the protein. False positive rates were calculated, as described previously (20) .
RNA isolation and cDNA synthesis for Q-PCR analysis. Total RNAs were isolated from the lung tissue of K-ras oncogene transgenic mouse to measure the quantity of the various genes or proteins. The lungs of K-ras transgenic mouse and nontransgenic mouse were collected and lysed using both TRIzol (Invitrogen) and homogenizer machine. The mixture was transferred to a new e-tube and was grinded by 1 ml needle. The mixture was centrifuged at 12,000 rpm for 10 min to remove the tissue debris and the supernatants were transferred to a new e-tube. Chloroform (200 μl) was added into the mixture and vortexed and then incubated at room temperature for 10 min until the mixture was divided into two layers. The mixture was centrifuged at 12,000 rpm for 10 min to remove the nuclear protein mixture. The supernatants were transferred to a new e-tube and 500 μl isopropanol was added to condense the RNA pellet. The mixture was centrifuged at 12,000 rpm for 20 min and the supernatants were discarded and then 1 ml of 75% ethanol was added to wash the pellet. The mixture was centrifuged at 12,000 rpm for 20 min and the supernatants were discarded. The pellet was dissolved in 100 μl diethylpyrocarbonate (DEPC)-treated water (Welgene, Daegu, Korea). Total RNAs were cleaned by RNeasy mini kit (Qiagen, Valencia, CA) according to the manufacturer's protocol. The concentration of RNAs was measured and 5 μg each RNA was used to synthesize cDNA. RNAs were boiled for 2 min to unfold the secondary structure of RNAs. Three micrograms of oligo dT was added and the mixture was incubated at 65˚C for 5 min. This step indicated that oligo dT was attached to poly A tail of RNAs. After incubation, 5 μl of 10X reverse transcription buffer (BioLabs, Ipswich, MA), reverse transcriptase (BioLabs), 250 μM dNTP and DEPC water were added into the previous mixture at 42˚C for 1 h.
Quantitative real-time PCR. Real-time PCR was performed with relative quantification protocol on a MiniOpticon™ real-time PCR system (Bio-Rad, Hercules, CA), using iQ™ SYBR ® -Green Supermix (Bio-Rad) for amplification detection. The real-time SYBR-Green assay was performed in a 20 μl reaction mixture with 2 μl of 25X diluted cDNA product, containing 1X iQ SYBR-Green Supermix (Bio-Rad) and 200 nM each primer. The PCR amplification profile was as follows: initial denaturation at 95˚C for 5 min; 40 cycles at 95˚C for 20 sec, Tm of samples for 20 sec and 72˚C for 20 sec. Optical data were collected after the annealing step of each cycle. Following PCR, reaction products were incubated for 1 min at 95˚C and then at 55˚C. PCR products were melted between 55˚C and 95˚C, then the temperature was increased up to 95˚C in 0.2˚C increments, 2 sec per increment. Optical data were collected over the duration of the temperature drop, with a dramatic increase in fluorescence occurring when the strands re-anneal. This was done to ensure that only one PCR product was amplified per reaction. Relative expression of the RT-PCR products was determined using the ΔΔCt method. This method calculates relative expression using the equation: Fold induction = 2^[-ΔΔCt], where Ct is the threshold cycle, i.e. the cycle number at which the sample's relative fluorescence rises above the background fluorescence and ΔΔCt = [Ct gene of interest (unknown sample) -Ct GAPDH (unknown sample)] -[Ct gene of interest (calibrator sample) -Ct CGAPDH (calibrator sample)]. Primers were purchased from M-biotech (Seoul, Korea). Primer pairs were chosen to minimize dimerization of primer and to generate an amplicon between 130 and 150 bp. All target genes were normalized to the housekeeping gene, glyceraldehyde 3-phosphate dehydrogenase (GAPDH), using primers (5'-ACCACAGTC CATGCCATCAC-3' as sense primer, 5'-TCCACCACCCTG TTGCTGTA-3' as antisense primer) and compared to normal mouse of the appropriate strain for relative expression values. One of the control samples, non-Tg mouse was chosen as the calibrator sample and used in each PCR. Each sample was run in triplicate and fold changes represent the ratio of K-ras Tg mice to control (non-Tg mice) expression values. The sequences of the primers are listed in Table I . Table I . Primer pairs used for real-time qPCR analysis of gene expression.
Results
Establishment of K-ras Tg mouse model and histopathological examination.
Histopathologically, several alveolar/bronchiolar hyperplasias and adenomas were observed in each lobe of the lung in the K-ras Tg mice (Fig. 1A ). Adenomas were induced as early as week 4 in all K-ras Tg mice. The size of K-ras gene product of PCR using genomic DNA was ~600 bp as expected in the lanes 1, 2, 3, 4, 5, 7 and 10 ( Fig. 1B) and these K-ras G12D Tg mice were used for analysis of K-ras modulators in mouse model of lung cancer and such genes were classified based on molecular function. Gene expression profiles of normal lungs and adenomas showed a distinct pattern in hierarchical clustering. Most of the up-regulated genes were included in area A of the hierarchical clustering and most of down-regulated genes were included in area B (Fig. 1C) .
Profiling analysis of genes modulated by K-ras oncogene. We classified up-and down-regulated genes with known functions based on molecular function ( Fig. 2A) and pathway (Fig. 2B) involved in biological processes. With regard to up-regulated genes involved in molecular function, the genes were classified into receptor, nucleic acid binding, defense/ immunity, oxidoreductase, kinase, hydrolase, etc. Also, downregulated genes involved in molecular function were classified into cytoskeleton proteins, transcription factor, extracellular matrix, etc. The classification based on pathway of K-ras induced genes includes T-cell activation, toll receptor signaling, Wnt signaling, p53 pathway, inflammation mediated by chemokine and cytokine signaling, Alzheimer disease presenilin pathway, interleukin signaling, angiogenesis, apoptosis signaling pathway, etc. Down-regulated genes involved in pathway function were classified into inflammation mediated by chemokine and cytokine signaling, interleukin signaling, angiogenesis, Wnt signaling, TGF-ß signaling pathway, endothelin, PDGF signaling pathway, cadherin signaling pathway, etc. Many genes, of which expression are considered to be regulated by K-ras, were found in their expression pattern obtained from microarray in a highly consistent manner of K-ras regulation and 40 and 31 genes upand down-regulated by K-ras were selected for quantitative real-time PCR analysis (Table II) .
Profiling analysis of protein modulated by K-ras oncogene.
Proteins modulated by K-ras oncogene were analyzed by LC-ESI-MS/MS. Total 653 proteins up-regulated and 263 proteins down-regulated by K-ras were classified by fold change, as shown in Table III . Proteins up-and downregulated by K-ras in lung tissue in K-ras Tg mice are listed in Table IV . Proteins up-and down-regulated by K-ras oncogene were annotated by categories based on the GO (http://www.geneontology.org/): biological process using the house-made FindGo program as shown in Fig. 3 . With regard to both up-and down-regulated proteins, the proteins were classified into proteolysis, cell adhesion, phosphorylation, development, cell cycle and cytokinesis, biological process, response, signal transduction, proliferation and apoptosis, translation and transcription and nucleotide, metabolism and catabolism, transport and localization, etc. Among the upregulated proteins, the proportion of proteins involved in metabolism and catabolism was large.
Validation of differentially expressed genes by real-time qPCR.
To verify the microarray analysis, we measured the expression levels of genes regulated by K-ras oncogene using real-time qPCR with 1X iQ SYBR-Green Supermix (BioRad). Total RNAs (5 μg) were isolated from the lung tissues of normal and K-ras TG mice and 25X diluted cDNAs from total RNAs were used for real-time qPCR analysis. Non-TG mice were used as negative control in this experiment. The expression levels of epiregulin (Ereg), interleukin-33 (IL-33), integrin · X (Itg·X) and annexin A4 (Anxa4) were significantly increased in the lung tissues of K-ras TG mice (>10-fold). We also confirmed that expression of genes regulated by K-ras oncogene [chemokine (C-C motif) receptor 1 (Ccr1), chemokine (C-C motif) ligand 6 (Ccr6), toll-like receptor 2 (Tlr2), C-type lectin domain family 4, member n (Clec4n), and 5',3'-nucleotidase, cytosolic (Nt5c)] were increased. Syndecan 1 (Sdc1), Cdc37 and glycosylationdependent cell adhesion molecule 1 (Glycam 1) were also increased 3. Table II . Up-and down-regulation of genes by K-ras oncogene. peroxiredoxin 3 (Prdx3), eukaryotic translation elongation factor 1 ß 2 (Eef1b2) and cytochrome b5 reductase 3 (Cyb5r3) were weakly increased (Fig. 4A) . The expression levels of T-cell receptor ß V13 (Tcrb-V13), chemokine binding protein 2 (Ccbp2), 5'-3' exoribonuclease 1 (Xrn 1), integrin ·8 (Itg·8), adenylate cyclase 8 (Adcy8), fibroblast growth factor receptor 4 (Fgfr4) were decreased by K-ras oncogene (Fig. 4B) . 
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Discussion
The ras proteins are pivotal regulators of cellular proliferation, differentiation, motility, and apoptosis (21) . K-ras oncogenes are frequently detected in mouse lung tumors (22) (23) (24) . Activating point mutations in the K-ras gene have been found in 30-50% of human lung adenocarcinomas and are believed to play a key role in this malignancy (25) . To analyze profiling of genes and proteins regulated by K-ras oncogene in lung tissue of K-ras Tg mice, K-ras G12D Tg mice, expressing mutant type K-ras gene in lung tissue by the regulation of SPC promoter sequence, were generated by the method of DNA microinjection into embryos of BDF1 mice as previously (18) . K-ras Tg mice and non-Tg mice were confirmed by PCR genotyping with detection of only transgene-specific sequence using genomic DNA. The K-ras gene was identified in transgenic mice. Total RNAs from the lung tissues of K-ras Tg mice were isolated and cDNAs were synthesized from RNAs. cDNA was used to analyze genes by using Affymetrix chips and proteins modulated by K-ras oncogene were analyzed by MALDI-TOF. In microarray analysis, the genes involved in the molecular function (nucleic acid binding, receptor and signaling molecule, etc.) and pathway (angiogenesis, inflammation mediated by chemokine and cytokine signaling, and apoptosis, etc.) were up-regulated, and the expression of several genes for biological processes showed a decreasing tendency in K-ras Tg mice. Also, proteins involved in metabolism and catabolism, transport and localization, proliferation and apoptosis, cell cycle, development were up-regulated by K-ras oncogene, whereas proteins were down-regulated by K-ras in metabolism and catabolism and (from 22 to 7%), transport and localization (from 19 to 18%), proliferation and apoptosis (from 5 to 4%), translation and transcription and nucleotide (from 6 to 4%). Genes and proteins related to carcinogenesis or K-ras mediated lung cancer were selected and the expression level of these genes was confirmed by real-time qPCR. The genes showed a similar expression pattern to the results of Omics analysis in real-time qPCR. Epiregulin, IL-33, integrin ·X, toll-like receptor 2, Clec4n and annexin A4 as candidate genes responsible for the enhanced carcinogenesis in K-ras Tg mice were significantly up-regulated by K-ras oncogene. Epiregulin, the newest member of the family of EGF-like ligands, is present in some normal human tissues and cancer cell lines. It may be involved in normal growth development and in cancer progression (26) . Recent studies have suggested that it is overexpressed in human prostate, colon, pancreatic and lung cancers (27) (28) (29) (30) . Toll-like receptor 2, a membrane receptor found at the surface of immune system Table III . Proteomics analysis of protein profiling of lung proteins modulated by K-ras oncogene. -48  <2  40  48  2-4  35  68  5-9  19  41  >10 559 79
Data files were extracted using Spectrum Mill Data Extractor with the parameters of [MH + ] 600 to 40000 and minimum signal-to-noise (S/N) 25. Searches were carried out against the human NCBInr database in both forward and reverse directions using the Spectrum Mill program (Agilent Technologies) with the following parameters: specific to trypsin with two missed cleavage; ±2.5 Da precursor-ion tolerance; and ±0.7 Da fragment-ion tolerance. The initial results were auto-validated as described in the Materials and methods section. Table IV . Up-and down-regulation of proteins by k-ras. (31, 32) . It was reported that TLR2 might be used for immunotherapy of malignant tumors (33) . IL-33 and Clec4n were involved in immune response and have cytokine and receptor activity, respectively. Clec4n has diverse functions, such as cell adhesion, signaling between cells (34, 35) . The expression levels of syndecan 1, chemokine (C-C motif) receptor 1, chemokine (C-C motif) ligand 6, cdc37 and glycam 1 were increased in K-ras Tg-mice. Syndecan, a cell surface proteoglycan, exhibits a molecular polymorphism during lung development (36) . Syndecan 1 might be involved in pathogenesis of human lung cancer and non-small cell lung carcinoma (37, 38) . Chemokine (C-C motif) receptor 1 and chemokine (C-C motif) ligand 6, which have an important role in the recruitment of leukocytes to the site of inflammation, promote tumorigenesis and metastasis, respectively (39) . The migration and metastasis of tumor cells share many similarities with leukocyte trafficking, which is mainly regulated by chemokine receptor-ligand interactions (40) . Glycam 1, a member of the glycoprotein mucin family and integrin ·X are involved in the cell adhesion and signal transduction (41, 42) . Cdc37, an essential component of the sevenless receptor/mitogen-activated kinase protein (MAPK) signaling pathway, is involved in cell division cycle (43) . The expression levels of Prdx3, Etfb, Eef1b2, Nt5c, and Cyb5r3 were weakly or negligibly increased by K-ras Table IVA . Continued. 
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